Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Bristol-Myers Squibb Company (BMY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bristol-Myers Squibb's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
44.86 +0.16    +0.36%
26/04 - Closed. Currency in USD ( Disclaimer )
After Hours
44.87
+0.01
+0.02%
0:57:36 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 19,818,157
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 44.34 - 45.37
Bristol-Myers Squibb 44.86 +0.16 +0.36%

BMY Balance Sheet

 
Featured here, the Balance Sheet for Bristol-Myers Squibb Company, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets - 31770 27632 28074
Cash and Short Term Investments 12280 12280 7685 8730
Cash - - - -
Cash & Equivalents - 11464 7514 8372
Short Term Investments - 816 171 358
Total Receivables, Net - 15264 15647 15059
Accounts Receivables - Trade, Net - 11337 10714 10517
Total Inventory - 2662 2436 2364
Prepaid Expenses - - - -
Other Current Assets, Total - 1564 1864 1921
Total Assets - 95159 91263 93489
Property/Plant/Equipment, Total - Net - 8036 7848 7629
Property/Plant/Equipment, Total - Gross - 12839 12499 12106
Accumulated Depreciation, Total - -4803 -4651 -4477
Goodwill, Net - 21169 21147 21163
Intangibles, Net - 27072 28950 31303
Long Term Investments - 2063 1882 1991
Note Receivable - Long Term - 3927 4933 4542
Other Long Term Assets, Total - 1868 1863 1287
Other Assets, Total - -7041 -9235 -8374
Total Current Liabilities - 22262 23462 20150
Accounts Payable - 3259 2813 3069
Payable/Accrued - - - -
Accrued Expenses - 11042 10763 9143
Notes Payable/Short Term Debt - 246 594 606
Current Port. of LT Debt/Capital Leases - 3035 5023 2582
Other Current liabilities, Total - 4680 4269 4750
Total Liabilities - 65674 62201 61459
Total Long Term Debt - 36710 32193 34679
Long Term Debt - 36710 32193 34679
Capital Lease Obligations - - - -
Deferred Income Tax - 338 399 751
Minority Interest - 55 64 57
Other Liabilities, Total - 6063 5489 5216
Total Equity 29485 29485 29062 32030
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 292 292 292
Additional Paid-In Capital - 45684 44849 45299
Retained Earnings (Accumulated Deficit) - 28766 28218 27449
Treasury Stock - Common - -43766 -43075 -39680
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 29485 -1491 -1222 -1330
Total Liabilities & Shareholders' Equity - 95159 91263 93489
Total Common Shares Outstanding 2027 2021 2034 2089
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BMY Comments

Write your thoughts about Bristol-Myers Squibb Company
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email